doi:10.19982/j.issn.1000-6621.20220270

Abstract

CLC Number:

Figures/Tables 5

References 19

[1]	Mise K, Goic-Barisic I, Puizina-Ivic N, et al. A rare case of pulmonary tuberculosis with simultaneous pulmonary and skin sarcoidosis: a case report. Cases J, 2010, 3:24. doi: 10.1186/1757-1626-3-24. doi: 10.1186/1757-1626-3-24 pmid: 20205764
[2]	Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet, 2014, 383(9923): 1155-1167. doi: 10.1016/S0140-6736(13)60680-7. doi: 10.1016/S0140-6736(13)60680-7 pmid: 24090799
[3]	Cho HS, Kim SJ, Yoo JY. Sarcoidosis during treatment of pulmonary tuberculosis: a rare case report and review of the literature. J Int Med Res, 2021, 49(4):3000605211001632. doi: 10.1177/03000605211001632. doi: 10.1177/03000605211001632
[4]	李廷东, 李文全. 一例肺结节病误诊为肺结核患者的临床分析. 结核与肺部疾病杂志, 2020, 1(4):289-292. doi: 10.3969/j.issn.2096-8493.2020.03.017. doi: 10.3969/j.issn.2096-8493.2020.03.017
[5]	Wang SH, Chung CH, Huang TW, et al. Bidirectional association between tuberculosis and sarcoidosis. Respirology, 2019, 24(5): 467-474. doi: 10.1111/resp.13482. doi: 10.1111/resp.13482 URL
[6]	Bennett D, Bargagli E, Refini RM, et al. New concepts in the pathogenesis of sarcoidosis. Expert Rev Respir Med, 2019, 13(10): 981-991. doi: 10.1080/17476348.2019.1655401. doi: 10.1080/17476348.2019.1655401 URL
[7]	Moravvej H, Vesal P, Abolhasani E, et al. Comorbidity of leishmania major with cutaneous sarcoidosis. Indian J Dermatol, 2014, 59(3): 316. doi: 10.4103/0019-5154.131453. doi: 10.4103/0019-5154.131453 pmid: 24891680
[8]	Agrawal R, Kee AR, Ang L, et al. Tuberculosis or sarcoidosis: opposite ends of the same disease spectrum? Tuberculosis (Edinb), 2016, 98: 21-26. doi: 10.1016/j.tube.2016.01.003. doi: 10.1016/j.tube.2016.01.003 URL
[9]	Mandal SK, Ghosh S, Mondal SS, et al. Coexistence of pulmonary tuberculosis and sarcoidosis: a diagnostic dilemma. BMJ Case Rep, 2014, 2014: bcr2014206016. doi: 10.1136/bcr-2014-206016. doi: 10.1136/bcr-2014-206016
[10]	Nunes H, Uzunhan Y, Gille T, et al. Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function. Eur Respir J, 2012, 40(3): 750-765. doi: 10.1183/09031936.00025212. doi: 10.1183/09031936.00025212 pmid: 22790910
[11]	Handa A, Dhooria S, Sehgal IS, et al. Primary cavitary sarcoidosis: A case report, systematic review, and proposal of new diagnostic criteria. Lung India, 2018, 35(1): 41-46. doi: 10.4103/lungindia.lungindia_225_17. doi: 10.4103/lungindia.lungindia_225_17 pmid: 29319033
[12]	Tuna T, Ozkaya S, Dirican A, et al. An intracerebral mass: tuberculosis or sarcoidosis? BMJ Case Rep, 2013, 2013: bcr2013009570. doi: 10.1136/bcr-2013-009570. doi: 10.1136/bcr-2013-009570
[13]	Bansal S, Utpat K, Desai U, et al. Sarcoidosis presenting with tracheobronchial calcification and nodularity: An unusual case presentation with treatment response assessment by ¹⁸F-FDG-PET/CT. Indian J Nucl Med, 2017, 32(3): 217-220. doi: 10.4103/ijnm.IJNM_152_16. doi: 10.4103/ijnm.IJNM_152_16 URL
[14]	中华医学会呼吸病学分会间质性肺疾病学组, 中国医师协会呼吸医师分会间质性肺疾病工作委员会. 中国肺结节病诊断和治疗专家共识. 中华结核和呼吸杂志, 2019, 42(9):685-693. doi: 10.3760/cma.j.issn.1001-0939.2019.09.007. doi: 10.3760/cma.j.issn.1001-0939.2019.09.007
[15]	Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J, 2021, 58(6):2004079. doi: 10.1183/13993003.04079-2020. doi: 10.1183/13993003.04079-2020
[16]	Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, et al. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients. Semin Arthritis Rheum, 2017, 47(2): 288-294. doi: 10.1016/j.semarthrit.2017.03.005. doi: 10.1016/j.semarthrit.2017.03.005 URL
[17]	Skowroński M, Halicka A, Barinow-Wojewódzki A. Pulmonary tuberculosis in a male with sarcoidosis. Adv Respir Med, 2019, 87(4): 252-253. doi: 10.5603/ARM.2019.0043. doi: 10.5603/ARM.2019.0043 pmid: 31476015
[18]	Kaur H, Singh D, Pandhi N. Co-existence of pulmonary tuberculosis with sarcoidosis. Int J Mycobacteriol, 2021, 10(3): 341-343. doi: 10.4103/ijmy.ijmy_145_21. doi: 10.4103/ijmy.ijmy_145_21 pmid: 34494579
[19]	Soskel NT, Sharma OP. Pleural involvement in sarcoidosis. Curr Opin Pulm Med, 2000, 6(5): 455-468. doi: 10.1097/00063198-200009000-00012. doi: 10.1097/00063198-200009000-00012 pmid: 10958239

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 19

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
[2]	Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407.
[3]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[4]	Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
[5]	Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431.
[6]	An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
[7]	Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443.
[8]	Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
[9]	Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
[10]	Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470.
[11]	Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476.
[12]	Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
[13]	Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497.
[14]	Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504.
[15]	Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512.